X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (44) 44
humans (38) 38
adult (26) 26
female (26) 26
male (26) 26
middle aged (20) 20
transplantation (20) 20
endocrinology & metabolism (19) 19
type 1 diabetes (19) 19
diabetes (18) 18
insulin (16) 16
treatment outcome (15) 15
diabetes mellitus (13) 13
diabetes mellitus, type 1 - blood (13) 13
diabetes mellitus, type 1 - surgery (12) 12
immunology (12) 12
abridged index medicus (9) 9
diabetes mellitus, type 1 - therapy (9) 9
islet transplantation (9) 9
c-peptide - blood (8) 8
care and treatment (8) 8
diabetes mellitus, type 1 - immunology (8) 8
glucose (8) 8
peptides (8) 8
research (8) 8
surgery (8) 8
animals (7) 7
blood glucose - metabolism (7) 7
transplants & implants (7) 7
adolescent (6) 6
allografts (6) 6
immunosuppression (6) 6
immunotherapy (6) 6
islet cells (6) 6
islets of langerhans transplantation (6) 6
pancreatic islet transplantation (6) 6
physiological aspects (6) 6
prevention (6) 6
progression (6) 6
risk factors (6) 6
autoantibodies (5) 5
autoimmunity (5) 5
cohort studies (5) 5
diabetes mellitus, type 1 - drug therapy (5) 5
graft (5) 5
hypoglycemia (5) 5
immunosuppressive agents - therapeutic use (5) 5
insulin - therapeutic use (5) 5
insulin-independence (5) 5
islets of langerhans transplantation - adverse effects (5) 5
liver segment (5) 5
pancreas (5) 5
aged (4) 4
antibodies (4) 4
beta cells (4) 4
biomarkers - blood (4) 4
child (4) 4
clinical trials (4) 4
drug therapy, combination (4) 4
glycemic control (4) 4
graft survival (4) 4
grafts (4) 4
health aspects (4) 4
hemoglobin (4) 4
hypoglycemic agents - therapeutic use (4) 4
insulin - blood (4) 4
insulin - metabolism (4) 4
insulin resistance (4) 4
internal medicine (4) 4
islets of langerhans transplantation - immunology (4) 4
medicine (4) 4
patients (4) 4
quality of life (4) 4
research article (4) 4
risk (4) 4
science (4) 4
tacrolimus (4) 4
transplantation, homologous (4) 4
young adult (4) 4
analysis (3) 3
autoantibodies - blood (3) 3
autoantibodies - immunology (3) 3
beta-cell function (3) 3
beta-cell mass (3) 3
beta-cells (3) 3
biomarkers (3) 3
blood sugar (3) 3
cells (3) 3
children (3) 3
complications and side effects (3) 3
diabetes mellitus, type 1 - pathology (3) 3
double-blind (3) 3
edmonton protocol (3) 3
endocrinology (3) 3
fasting (3) 3
glomerular filtration rate (3) 3
glucose clamp technique (3) 3
glucose tolerance test (3) 3
glycated hemoglobin a - analysis (3) 3
graft rejection (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 06/2008, Volume 3, Issue 6, pp. e2435 - e2435
Journal Article
PloS one, ISSN 1932-6203, 2017, Volume 12, Issue 6, pp. e0179108 - e0179108
[This corrects the article DOI: 10.1371/journal.pone.0166702.]. 
Insulin | Automation | Diabetes mellitus
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, pp. e0166702 - e0166702
Journal Article
Diabetes care, ISSN 0149-5992, 09/2018, Volume 41, Issue 9, pp. 1938 - 1946
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 06/2015, Volume 100, Issue 6, pp. 2314 - 2321
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 06/2018, Volume 20, Issue 6, pp. i - i
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9788, pp. 291 - 292
Journal Article
Diabetologia, ISSN 0012-186X, 7/2018, Volume 61, Issue 7, pp. 1623 - 1632
HLA-A*24 carriership hampers achievement of insulin independence in islet allograft recipients. However, less than half of those who fail to achieve insulin... 
Body mass index | Genetics of type 1 diabetes | Medicine & Public Health | Human Physiology | Zinc transporter 8 | Metabolic Diseases | HLA class I | Human islet transplantation | Internal Medicine | HLAclass I | AUTOANTIGEN | ZINC-TRANSPORTER | TRANSPLANTATION | ZNT8 | AUTOIMMUNITY | ENDOCRINOLOGY & METABOLISM | BETA-CELL MASS | MUTATIONS | TYPE-1 | PROGRESSION | HLA ANTIBODIES | Zinc Transporter 8 - genetics | Diabetes Mellitus, Type 1 - surgery | Humans | Middle Aged | HLA-A24 Antigen - genetics | Male | Recovery of Function | Insulin-Secreting Cells - metabolism | Allografts | Islets of Langerhans Transplantation - adverse effects | Female | Retrospective Studies | Diabetes Mellitus, Type 1 - immunology | Body Mass Index | Hypoglycemic Agents - therapeutic use | HLA-A24 Antigen - immunology | Risk Factors | Diabetes Mellitus, Type 1 - genetics | Treatment Outcome | Clinical Trials as Topic | Biomarkers - blood | Insulin-Secreting Cells - immunology | Polymorphism, Genetic | Blood Glucose - drug effects | Diabetes Mellitus, Type 1 - blood | Blood Glucose - metabolism | Insulin - therapeutic use | Insulin-Secreting Cells - transplantation | Histocompatibility antigens | Peptides | Type 1 diabetes | Immunotherapy | Body weight | HLA histocompatibility antigens | Resveratrol | Transplantation of organs, tissues, etc | Genetic aspects | Risk factors | Genetic polymorphisms | Diabetes mellitus | Pancreatic islet transplantation | Clinical trials | Data processing | Multivariate analysis | Metabolism | Gene polymorphism | Insulin | Zinc transporter | Beta cells | Immunosuppression | Alleles | Histocompatibility antigen HLA | Pancreas | Index Medicus
Journal Article
The Lancet Diabetes & Endocrinology, ISSN 2213-8587, 05/2019, Volume 7, Issue 5, pp. 330 - 331
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2006, Volume 103, Issue 46, pp. 17444 - 17449
Journal Article
PLoS ONE, ISSN 1932-6203, 2016, Volume 11, Issue 1, pp. e0146649 - e0146649
BACKGROUND: Islet cell transplantation holds a potential cure for type 1 diabetes, but many islet recipients do not reach long-lasting insulin independence. In... 
EFFECTOR T-CELLS | MULTIPLEX IMMUNOASSAY | IMMUNOSUPPRESSION | ALLOGRAFT | MULTIDISCIPLINARY SCIENCES | INTENSIVE MEDICAL THERAPY | KIDNEY INJURY MOLECULE-1 | PANCREATIC-CELLS | DIFFERENTIATION | INFLAMMATORY CYTOKINES | PROGRESSION | Immunosuppressive Agents | Humans | Middle Aged | Male | Treatment Outcome | Adipokines - metabolism | Biomarkers - blood | Diabetes Mellitus, Type 1 - therapy | Immunosuppression | Insulin - metabolism | Diabetes Mellitus, Type 1 - blood | Islets of Langerhans - cytology | Islets of Langerhans Transplantation | Adult | Female | Chemokines - metabolism | Cohort Studies | Cytokines - blood | Care and treatment | Cytokines | Type 1 diabetes | Islands of Langerhans | Physiological aspects | Genetic aspects | Research | Blood transfusions | Multiplexing | Pediatrics | Immunoassay | Transplants & implants | Laboratories | Syngeneic grafts | Interleukin 22 | Transplantation | Interleukin 1 receptors | Serum proteins | Grafting | Proteins | Allografts | Immunology | Lymphocytes | Rodents | Immunotherapy | Cell cycle | Bioindicators | Cathepsin L | Kidneys | Diabetes mellitus | Macrophage colony-stimulating factor | Pancreatic islet transplantation | CCL3 protein | Insulin | Patients | Interleukin 16 | Studies | Brain-derived neurotrophic factor | Grafts | Leptin | Islet cells | Biomarkers | Insulin resistance | Interferon | Diabetes | Chemokines | Endocrinology | Index Medicus
Journal Article
Transplantation, ISSN 0041-1337, 04/2019, p. 1
BACKGROUND.In simultaneous pancreas kidney (SPK) transplant recipients, the majority of complications described in the literature, are early postoperative... 
Journal Article